PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.85%
Revenue decline while 3088.T shows 4.56% growth. Joel Greenblatt would examine competitive position erosion.
-2.97%
Cost reduction while 3088.T shows 3.59% growth. Joel Greenblatt would examine competitive advantage.
-2.33%
Gross profit decline while 3088.T shows 6.44% growth. Joel Greenblatt would examine competitive position.
0.53%
Margin expansion below 50% of 3088.T's 1.80%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.87%
Other expenses growth less than half of 3088.T's 26.46%. David Dodd would verify if advantage is sustainable.
2.76%
Operating expenses growth 50-75% of 3088.T's 4.17%. Bruce Berkowitz would examine efficiency.
-2.03%
Total costs reduction while 3088.T shows 3.76% growth. Joel Greenblatt would examine advantage.
-5.56%
Interest expense reduction while 3088.T shows 7.14% growth. Joel Greenblatt would examine advantage.
5.15%
D&A growth 1.25-1.5x 3088.T's 4.11%. Martin Whitman would scrutinize asset base.
-12.82%
EBITDA decline while 3088.T shows 15.40% growth. Joel Greenblatt would examine position.
-10.26%
EBITDA margin decline while 3088.T shows 10.37% growth. Joel Greenblatt would examine position.
-23.85%
Operating income decline while 3088.T shows 15.21% growth. Joel Greenblatt would examine position.
-21.62%
Operating margin decline while 3088.T shows 10.18% growth. Joel Greenblatt would examine position.
13.16%
Other expenses growth less than half of 3088.T's 76.62%. David Dodd would verify if advantage is sustainable.
-21.37%
Pre-tax income decline while 3088.T shows 18.54% growth. Joel Greenblatt would examine position.
-19.06%
Pre-tax margin decline while 3088.T shows 13.37% growth. Joel Greenblatt would examine position.
-20.17%
Tax expense reduction while 3088.T shows 24.53% growth. Joel Greenblatt would examine advantage.
-21.96%
Net income decline while 3088.T shows 15.37% growth. Joel Greenblatt would examine position.
-19.67%
Net margin decline while 3088.T shows 10.34% growth. Joel Greenblatt would examine position.
-22.00%
EPS decline while 3088.T shows 15.37% growth. Joel Greenblatt would examine position.
-22.00%
Diluted EPS decline while 3088.T shows 15.38% growth. Joel Greenblatt would examine position.
0.06%
Share count increase while 3088.T reduces shares. John Neff would investigate differences.
0.06%
Diluted share increase while 3088.T reduces shares. John Neff would investigate differences.